COREY BUCK: Open Payments
NPI 1881364552 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 20 payments from 6 companies in 2025. Trend: 2023 $370 · 2024 $433 · 2025 $565
Food & beverage: $509Education: $56
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $238 |
| AstraZeneca Pharmaceuticals LP | 2 | $150 |
| GENZYME CORPORATION | 4 | $83 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $17 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, JOURNAVX, INSPIRE.
Industry payments across IN — which companies pay providers there.
